Faron Pharmaceuticals Oy (AIM:FARN)
London flag London · Delayed Price · Currency is GBP · Price in GBX
40.50
-0.50 (-1.22%)
Jul 24, 2026, 1:02 PM GMT

Faron Pharmaceuticals Oy Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
------
Revenue Growth
------
Gross Profit
------
Operating Income
-20.27-20.27-18.67-28.57-27.43-21.11
Net Income
-27.26-27.26-25.92-30.94-28.73-21.19
Earnings Per Share
-0.24-0.24-0.29-0.48-0.52-0.42
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
12.3212.329.56.886.996.85
Total Debt
24.6824.6812.1113.1113.273.55
Net Cash (Debt)
-12.36-12.36-2.61-6.24-6.283.31
Net Cash Growth
-----274.41%
Net Cash Per Share
-0.11-0.11-0.03-0.10-0.110.07

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-17.92-17.92-22.3-23.81-22.99-22.22
Capital Expenditures
---0---0.01
Free Cash Flow
-17.92-17.92-22.31-23.81-22.99-22.23
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
------